4 Largecap Stocks With 20-30 Per Cent Revenue Growth and ROE Above 20 to Watch for Future Multibagger Potential: Eicher Motors, Torrent Pharma, Polycab and Marico
- October 22, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Eicher Motors Rs 7,170.50. Torrent Pharma Rs 4,553.80. Polycab Rs 7,770.50. Marico Rs 775.65. Market caps from Rs 1.02 lakh crore to Rs 1.94 lakh crore. Data as of 21 Oct 2026.
Quick Answer
Eicher Motors, Torrent Pharma, Polycab and Marico are the 4 picks in this stocks with 20-30 per cent revenue growth and ROE above 20 watchlist, with market caps between Rs 1.02 lakh crore and Rs 1.94 lakh crore. Eicher Motors stands out for the fastest profit growth, 34.67% a year since FY22, while Torrent Pharma offers 20.34% revenue growth in FY26. PE ratios run from 33.62 to 81.26, so compare each one with its industry PE before investing. All figures are as of 21 October 2026.
Stocks with 20-30 per cent revenue growth and ROE above 20 to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Eicher Motors, Torrent Pharma, Polycab and Marico meet that test, with market caps from Rs 1.02 lakh crore to Rs 1.94 lakh crore and Eicher Motors offering the fastest profit growth, 34.67% a year since FY22. Each of these companies has FY26 revenue growth between 20 and 30 per cent and a return on equity above 20 per cent, and net profit rose in FY26 and in the latest quarter.
This list covers companies with FY26 revenue growth between 20 and 30 per cent and a return on equity above 20 per cent, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening stocks with 20-30 per cent revenue growth and ROE above 20 usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 21 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Stocks With 20-30 Per Cent Revenue Growth and ROE Above 20 and Why Do They Attract Multibagger Interest?
Stocks with 20-30 per cent revenue growth and ROE above 20 are shares of businesses that grew sales at a fast pace and still earn high returns on shareholder money. The four here cover premium motorcycles, pharmaceuticals, cables and consumer goods.
Fast growth with high returns is what long-term compounding looks like. For stocks with 20-30 per cent revenue growth and ROE above 20, rising profit adds to the case. Whichever way you read stocks with 20-30 per cent revenue growth and ROE above 20, the common thread is rising profit backed by complete financial data. Each of stocks with 20-30 per cent revenue growth and ROE above 20 also has complete FY26 and latest quarter figures. Investors researching stocks with 20-30 per cent revenue growth and ROE above 20 get a fuller picture by reading growth and valuation together. The table below lines up stocks with 20-30 per cent revenue growth and ROE above 20 on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use stocks with 20-30 per cent revenue growth and ROE above 20 as a starting point for your own research.
Stocks With 20-30 Per Cent Revenue Growth and ROE Above 20 at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 21 October 2026. Eicher Motors has the lowest PE of the group at 33.62, while Marico posts the highest return on equity at 41.85%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Eicher Motors | 7,170.50 | 1,94,090 | 33.62 | 23.82 | 21.97% | 0.02 | 6,442.00 to 8,230.00 |
| Torrent Pharmaceuticals | 4,553.80 | 1,75,196 | 81.26 | 36.42 | 25.49% | 1.79 | 3,480.60 to 5,250.00 |
| Polycab India | 7,770.50 | 1,25,388 | 43.16 | 49.96 | 22.25% | 0.02 | 6,663.00 to 10,126.00 |
| Marico | 775.65 | 1,02,404 | 52.47 | 34.68 | 41.85% | 0.13 | 705.20 to 889.10 |
Eicher Motors: 34.67% Profit CAGR Since FY22
Eicher Motors owns the Royal Enfield brand of premium motorcycles and is a partner in the Eicher commercial vehicle business. It reported FY26 revenue of Rs 24,894.09 crore, up 23.39% year on year, and net profit of Rs 5,515.23 crore, up 16.49%. Net profit has compounded at 34.67% a year since FY22, while revenue has grown 23.39% a year. Operating margin was 34.24% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.
In the June 2026 quarter, revenue rose 29.35% to Rs 7,098.73 crore and net profit grew 21.35% to Rs 1,462.51 crore. The share price has gained 174.76% over five years. The stock trades at a PE of 33.62 against an industry PE of 23.82, with a return on equity of 21.97%.
Torrent Pharma: 28.79% Profit CAGR Since FY22
Torrent Pharmaceuticals makes branded medicines for chronic therapies such as cardiac, gastro-intestinal and central nervous system care in India and overseas. It reported FY26 revenue of Rs 13,886.15 crore, up 20.34% year on year, and net profit of Rs 2,138.18 crore, up 11.87%. Net profit has compounded at 28.79% a year since FY22, while revenue has grown 12.38% a year. Operating margin was 22.70% in FY26.
The stock trades at a PE of 81.26 against an industry PE of 36.42, with a return on equity of 25.49%. In the June 2026 quarter, revenue rose 56.29% to Rs 4,909 crore and net profit grew 3.28% to Rs 566 crore. The share price has gained 194.63% over five years and 29.72% over the past year. Domestic institutions raised their holding from 9.28% in September 2025 to 12.87% in July 2026.
Polycab: 33.79% Profit CAGR Since FY22
Polycab India is a leading maker of wires and cables in India, with a growing fast-moving electrical goods business. It reported FY26 revenue of Rs 29,120.04 crore, up 28.76% year on year, and net profit of Rs 2,708.43 crore, up 32.41%. Net profit has compounded at 33.79% a year since FY22, while revenue has grown 24.06% a year. Operating margin was 14.69% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.
In the June 2026 quarter, revenue rose 38.90% to Rs 8,314.65 crore and net profit grew 32.84% to Rs 796.65 crore. The share price has gained 230.55% over five years. Foreign investors raised their holding from 11.44% in June 2025 to 19.00% in June 2026. The stock trades at a PE of 43.16 against an industry PE of 49.96, below the sector average, with a return on equity of 22.25%.
Marico: Revenue Up 25.15% in FY26
Marico owns consumer brands such as Parachute, Saffola and Nihar and sells hair care, edible oils and food products in India and abroad. It reported FY26 revenue of Rs 13,815 crore, up 25.15% year on year, and net profit of Rs 1,813 crore, up 9.35%. Net profit has compounded at 9.63% a year since FY22, while revenue has grown 9.50% a year. Operating margin was 16.21% in FY26. The debt-to-equity ratio is 0.13, which keeps interest costs low.
The stock trades at a PE of 52.47 against an industry PE of 34.68, with a return on equity of 41.85%. In the June 2026 quarter, revenue rose 22.22% to Rs 4,005 crore and net profit grew 27.10% to Rs 652 crore. Domestic institutions raised their holding from 12.71% in June 2025 to 13.02% in June 2026.
Stocks With 20-30 Per Cent Revenue Growth and ROE Above 20: Financial Comparison on Growth and Margins
The table compares scale and growth across these stocks with 20-30 per cent revenue growth and ROE above 20. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Eicher Motors | 24,894.09 | 5,515.23 | 23.39% | 23.39% | 34.67% | 34.28% |
| Torrent Pharma | 13,886.15 | 2,138.18 | 20.34% | 12.38% | 28.79% | 33.73% |
| Polycab | 29,120.04 | 2,708.43 | 28.76% | 24.06% | 33.79% | 15.12% |
| Marico | 13,815 | 1,813 | 25.15% | 9.50% | 9.63% | 21.91% |
Institutional Holding in Eicher Motors, Torrent Pharma, Polycab and Marico
Institutional holding shows who is backing these stocks with 20-30 per cent revenue growth and ROE above 20 alongside the promoter. The table uses the latest reported quarter for each. Eicher Motors has the deepest institutional backing, with FII and DII together holding 41.59% as of June 2026. Domestic institutions increased their holding over the past year in Torrent Pharma (from 9.28% to 12.87%) and Marico (from 12.71% to 13.02%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Eicher Motors | 49.02% | 25.53% | 16.06% | 9.40% | June 2026 |
| Torrent Pharma | 60.78% | 17.97% | 12.87% | 8.38% | July 2026 |
| Polycab | 61.46% | 19.00% | 7.62% | 11.92% | June 2026 |
| Marico | 58.91% | 23.40% | 13.02% | 4.66% | June 2026 |
Risks to Weigh in Stocks With 20-30 Per Cent Revenue Growth and ROE Above 20
Being careful with stocks with 20-30 per cent revenue growth and ROE above 20 means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Torrent Pharma trades at a PE of 81.26 against an industry PE of 36.42, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Stocks With 20-30 Per Cent Revenue Growth and ROE Above 20
Picking from stocks with 20-30 per cent revenue growth and ROE above 20 comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (23.82 to 49.96) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Eicher Motors, Torrent Pharma, Polycab and Marico live prices.
Conclusion
Among stocks with 20-30 per cent revenue growth and ROE above 20, Eicher Motors stands out for the fastest profit growth, 34.67% a year since FY22, Torrent Pharma for 20.34% revenue growth in FY26, Polycab for the biggest five-year price gain at 230.55% and Marico for the highest return on equity at 41.85%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing stocks with 20-30 per cent revenue growth and ROE above 20 should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Stocks With 20-30 Per Cent Revenue Growth and ROE Above 20 to Watch
Which are the best stocks with 20-30 per cent revenue growth and ROE above 20 to watch for multibagger potential?
Ans. Eicher Motors, Torrent Pharma, Polycab and Marico are the 4 names this list highlights, with market caps of Rs 1,94,090 crore, Rs 1,75,196 crore, Rs 1,25,388 crore and Rs 1,02,404 crore respectively. Eicher Motors is notable for the fastest profit growth, 34.67% a year since FY22. Torrent Pharma stands out for 20.34% revenue growth in FY26. Polycab offers the biggest five-year price gain at 230.55%. Marico brings the highest return on equity at 41.85%. These are watchlist names for stocks with 20-30 per cent revenue growth and ROE above 20, not recommendations, so match each one to your own risk profile and time horizon.
Is Marico a good stock for long-term investors?
Ans. Marico has a return on equity of 41.85%, a PE of 52.47 against an industry PE of 34.68 and a market cap of Rs 1,02,404 crore. Net profit has compounded at 9.63% a year since FY22, and FY26 revenue rose 25.15% while June 2026 quarter net profit grew 27.10%. Long-term returns in stocks with 20-30 per cent revenue growth and ROE above 20 depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Eicher Motors become a multibagger from here?
Ans. Eicher Motors has already gained 174.76% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks with 20-30 per cent revenue growth and ROE above 20 requires earnings to keep growing faster than the market for several years. Net profit has compounded at 34.67% a year since FY22, and FY26 revenue rose 23.39%. At a PE of 33.62 against an industry PE of 23.82, valuation should be checked against that growth before investing.
What is the market cap of Eicher Motors, Torrent Pharma, Polycab and Marico?
Ans. As of 21 October 2026, Eicher Motors has a market cap of Rs 1,94,090 crore, Torrent Pharma has a market cap of Rs 1,75,196 crore, Polycab has a market cap of Rs 1,25,388 crore and Marico has a market cap of Rs 1,02,404 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks with 20-30 per cent revenue growth and ROE above 20.
What are the risks of investing in stocks with 20-30 per cent revenue growth and ROE above 20?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Torrent Pharma trades at a PE of 81.26 against an industry PE of 36.42, so earnings growth needs to hold up.
Why is Torrent Pharma trading at a PE of 81.26?
Ans. Torrent Pharma’s PE of 81.26 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 25.49%, profit growth of 28.79% a year since FY22 and FY26 revenue growth of 20.34%, which also means the stock is more sensitive if growth slows. Investors in stocks with 20-30 per cent revenue growth and ROE above 20 who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Eicher Motors, Torrent Pharma, Polycab and Marico?
Ans. As of the latest reported quarter, FII and DII together hold 41.59% of Eicher Motors (25.53% and 16.06%), 30.84% of Torrent Pharma (17.97% and 12.87%), 26.62% of Polycab (19.00% and 7.62%) and 36.42% of Marico (23.40% and 13.02%). Rising institutional holding is a useful signal in stocks with 20-30 per cent revenue growth and ROE above 20, though it should be read with earnings trends rather than on its own.
